Cargando…
Trimetazidine in Heart Failure
Heart failure is a systemic syndrome caused by multiple pathological factors. Current treatments do not have satisfactory outcomes. Several basic studies have revealed the protective effect of trimetazidine on the heart, not only by metabolism modulation but also by relieving myocardial apoptosis, f...
Autores principales: | Shu, Hongyang, Peng, Yizhong, Hang, Weijian, Zhou, Ning, Wang, Dao Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883591/ https://www.ncbi.nlm.nih.gov/pubmed/33597865 http://dx.doi.org/10.3389/fphar.2020.569132 |
Ejemplares similares
-
Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK
por: Shu, Hongyang, et al.
Publicado: (2021) -
Emerging role of VCP/p97 in cardiovascular diseases: novel insights and therapeutic opportunities
por: Shu, Hongyang, et al.
Publicado: (2021) -
The role of CD36 in cardiovascular disease
por: Shu, Hongyang, et al.
Publicado: (2020) -
Emerging Roles of Ceramide in Cardiovascular Diseases
por: Shu, Hongyang, et al.
Publicado: (2022) -
Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1
por: Yang, Yong, et al.
Publicado: (2020)